All sections · Part V: Shares · Sub-Part IV: Distributions
71 细胞和非细胞的分布由专有的细胞公司负责
(1) 在不违反第72条和公司的组织章程或章程细则所产生的任何其他要求的情况下，受保护单元公司的董事可以在任何时候授权对一个单元进行分配（单元分配），如果他们有合理的理由相信，在分配之后，受保护单元公司将满足根据第(2)款所适用的偿付能力测试。
(2) 在确定受保护的细胞公司是否符合第(1)款规定的偿付能力测试，以便对细胞进行分配时，不应考虑到--。
归属于该实体的另一个单元的资产和负债；或
(b) 该实体的非细胞资产和负债。
(3) 在不违反第72条和公司的组织章程或章程细则所产生的任何其他要求的情况下，如果受保护单元公司的董事有合理的理由相信受保护单元公司将在紧接着的分配之后满足第(4)款所适用的偿付能力测试，他们可以在任何时候授权就其非单元资产和负债进行分配（非单元分配）。
(4) 在确定受保护单元公司是否满足第(3)款的偿付能力测试以进行非单元分配时，受保护单元公司的某一单元的资产和负债不应考虑在内，除非根据第十三部分第四款的规定，受保护单元公司的非单元资产可用于满足受保护单元公司的某一单元有权获得的负债。
(2) 在确定受保护的细胞公司是否符合第(1)款规定的偿付能力测试，以便对细胞进行分配时，不应考虑到--。
归属于该实体的另一个单元的资产和负债；或
(b) 该实体的非细胞资产和负债。
(3) 在不违反第72条和公司的组织章程或章程细则所产生的任何其他要求的情况下，如果受保护单元公司的董事有合理的理由相信受保护单元公司将在紧接着的分配之后满足第(4)款所适用的偿付能力测试，他们可以在任何时候授权就其非单元资产和负债进行分配（非单元分配）。
(4) 在确定受保护单元公司是否满足第(3)款的偿付能力测试以进行非单元分配时，受保护单元公司的某一单元的资产和负债不应考虑在内，除非根据第十三部分第四款的规定，受保护单元公司的非单元资产可用于满足受保护单元公司的某一单元有权获得的负债。
Translation for information only. Only the English original is legally binding.
Original wording (English, legally binding): Cellular and non-cellular distributions by protected cell company
(1) Subject to section 72 and to any other requirement imposed by the
memorandum or articles of the company, the directors of a protected cell
by protected cell
company may authorise a distribution in respect of a cell („cellular
distribution“) at any time if they are satisfied, on reasonable grounds, that
the protected cell company will, immediately after the distribution, satisfy
the solvency test as it applies by virtue of subsection (2).
(2) In determining whether a protected cell company satisfies the solvency test
under subsection (1) for the purpose of making a cellular distribution in
respect of a cell, no account is to be taken of —
(a) the assets and liabilities, attributable to any other cell of the
company; or
(b) non-cellular assets and liabilities of the company.
(3) Subject to section 72 and to any other requirement imposed by the
memorandum or articles of the company, the directors of a protected cell
company may authorise a distribution in respect of its non-cellular assets
and liabilities (a „non-cellular distribution“) at any time if they are
satisfied, on reasonable grounds, that the protected cell company will,
immediately after the distribution, satisfy the solvency test as it applies by
virtue of subsection (4).
(4) In determining whether a protected cell company satisfies the solvency test
under subsection (3) for the purposes of making a non-cellular distribution,
no account need be taken of the assets and liabilities of any cell of the
protected cell company, except in the respect of any liability arising
pursuant to Sub-Part IV of Part XIII by which the protected cell company‘s
non-cellular assets may be utilised to meet any liability attributable to any
cell of a protected cell company.
memorandum or articles of the company, the directors of a protected cell
by protected cell
company may authorise a distribution in respect of a cell („cellular
distribution“) at any time if they are satisfied, on reasonable grounds, that
the protected cell company will, immediately after the distribution, satisfy
the solvency test as it applies by virtue of subsection (2).
(2) In determining whether a protected cell company satisfies the solvency test
under subsection (1) for the purpose of making a cellular distribution in
respect of a cell, no account is to be taken of —
(a) the assets and liabilities, attributable to any other cell of the
company; or
(b) non-cellular assets and liabilities of the company.
(3) Subject to section 72 and to any other requirement imposed by the
memorandum or articles of the company, the directors of a protected cell
company may authorise a distribution in respect of its non-cellular assets
and liabilities (a „non-cellular distribution“) at any time if they are
satisfied, on reasonable grounds, that the protected cell company will,
immediately after the distribution, satisfy the solvency test as it applies by
virtue of subsection (4).
(4) In determining whether a protected cell company satisfies the solvency test
under subsection (3) for the purposes of making a non-cellular distribution,
no account need be taken of the assets and liabilities of any cell of the
protected cell company, except in the respect of any liability arising
pursuant to Sub-Part IV of Part XIII by which the protected cell company‘s
non-cellular assets may be utilised to meet any liability attributable to any
cell of a protected cell company.
